Similar contrasting patterns of expression were noted underlying the role of FTExT genes: CYBA, GNAI2, GRN, JAK3, TRADD, BCL2A1, BPGM, and CD48 in carcinomas of the breast and other tissues, in comparison to myeloma. This evidence concerns the gene BCL2A1 and carcinoma.